{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:06:51Z","timestamp":1772464011654,"version":"3.50.1"},"reference-count":56,"publisher":"American Veterinary Medical Association (AVMA)","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"sc_a1\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the efficacy of topical penciclovir 1% cream for the treatment of cats with experimentally induced ocular feline herpesvirus-1 (FHV-1) infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a2\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A randomized, placebo-controlled trial was performed using 10 unvaccinated specific-pathogen-free cats with experimental FHV-1 infection induced by topical ocular inoculation. Cats received topical penciclovir 1% cream (n = 6 cats) or a placebo artificial tear gel (4) 3 times daily for 14 days. Cats were monitored after inoculation for 30 days. Ophthalmic examinations were performed every 2 days, and ocular disease scores were calculated. In vivo confocal microscopic ocular examinations were performed to quantify corneal leukocytes. Feline herpesvirus-1 quantitative PCR, viral titers, hemograms, and serum biochemistry panels were performed throughout the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a3\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No significant differences in clinical ocular disease scores were observed between the penciclovir and placebo groups during the majority of the study period; however, penciclovir-treated cat scores declined more rapidly after study day 14. No significant differences were detected in corneal leukocyte infiltrates between study groups. Ocular viral loads determined by PCR were significantly lower in the penciclovir group on day 3 but were similar on all other sampling days. Hemogram and serum biochemistry values were unremarkable in all cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a4\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Topical penciclovir 1% cream administered 3 times daily was well tolerated and modestly reduced ocular viral shedding but had minimal effects on clinical ocular disease in cats with experimental ocular FHV-1 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a5\">\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>Refinements in the topical penciclovir treatment strategies and optimization of penciclovir formulations are recommended before clinical applications in cats.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2460\/ajvr.25.08.0304","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:55:44Z","timestamp":1765997744000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of topical ophthalmic application of penciclovir cream in cats with experimental ocular feline herpesvirus-1 infection"],"prefix":"10.2460","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1894-8839","authenticated-orcid":true,"given":"Eric C.","family":"Ledbetter","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Ramos-Bartolomei","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio L. C.","family":"Brito","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty Qualittas, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vianna V.","family":"Bassani","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2465-8082","authenticated-orcid":true,"given":"George C.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Moravek","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kobi M.","family":"Rassnick","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella L.","family":"Raux","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn","family":"Yockey","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8715-2562","authenticated-orcid":true,"given":"Rebecca M.","family":"Harman","sequence":"additional","affiliation":[{"name":"Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-8029","authenticated-orcid":true,"given":"Gerlinde R.","family":"Van de Walle","sequence":"additional","affiliation":[{"name":"Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1189-8664","authenticated-orcid":true,"given":"Ursula","family":"Krotscheck","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"issue":"2","key":"B1","series-title":"Vet Res","first-page":"337","article-title":"Feline herpesvirus","volume":"38","author":"Gaskell R","year":"2007","unstructured":"Gaskell R, Dawson S, Radford A, Thiry E. Feline herpesvirus. Vet Res. 2007;38(2):337\u2013354. doi:10.1051\/vetres:2006063"},{"issue":"5","key":"B2","series-title":"J Feline Med Surg","first-page":"333","article-title":"Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options","volume":"13","author":"Gould D","year":"2011","unstructured":"Gould D. Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options. J Feline Med Surg. 2011;13(5):333\u2013346. doi:10.1016\/j.jfms.2011.03.010"},{"issue":"2","key":"B3","series-title":"Am J Vet Res","first-page":"289","article-title":"Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats","volume":"69","author":"Fontenelle JP","year":"2008","unstructured":"Fontenelle JP, Powell CC, Veir JK, Radecki SV, Lappin MR. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res. 2008;69(2):289\u2013293. doi:10.2460\/ajvr.69.2.289"},{"issue":"5","key":"B4","series-title":"J Ocul Pharmacol Ther","article-title":"Comparative efficacy of topical ophthalmic ganciclovir and Oral famciclovir in cats with experimental ocular feline herpesvirus-1 epithelial infection","volume":"38","author":"Ledbetter EC","year":"2022","unstructured":"Ledbetter EC, Badanes ZI, Chan RX, et al. Comparative efficacy of topical ophthalmic ganciclovir and Oral famciclovir in cats with experimental ocular feline herpesvirus-1 epithelial infection. J Ocul Pharmacol Ther. 2022;38(5): doi:10.1089\/jop.2022.0001"},{"issue":"4","key":"B5","series-title":"Am J Vet Res","first-page":"399","article-title":"In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1","volume":"65","author":"Maggs DJ","year":"2004","unstructured":"Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res. 2004;65(4):399\u2013403. doi:10.2460\/ajvr.2004.65.399"},{"issue":"3","key":"B6","series-title":"Antiviral Res","first-page":"268","article-title":"Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase","volume":"78","author":"Hussein ITM","year":"2008","unstructured":"Hussein ITM, Menashy RB, Field HJ. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase. Antiviral Res. 2008;78(3):268\u2013274. doi:10.1016\/j.antiviral.2007.10.015"},{"issue":"1","key":"B7","series-title":"Am J Vet Res","first-page":"85","article-title":"Evaluation of orally administered famciclovir in cats experimentally infected with feline herpesvirus type-1","volume":"72","author":"Thomasy SM","year":"2011","unstructured":"Thomasy SM, Lim CC, Reilly CM, Kass PH, Lappin MR, Maggs DJ. Evaluation of orally administered famciclovir in cats experimentally infected with feline herpesvirus type-1. Am J Vet Res. 2011;72(1):85\u201395. doi:10.2460\/ajvr.72.1.85"},{"issue":"5","key":"B8","series-title":"J Am Vet Med Assoc","first-page":"526","article-title":"Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006\u20132013)","volume":"249","author":"Thomasy SM","year":"2016","unstructured":"Thomasy SM, Shull O, Outerbridge CA, et al. Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006\u20132013). J Am Vet Med Assoc. 2016;249(5):526\u2013538. doi:10.2460\/javma.249.5.526"},{"issue":"1","key":"B9","series-title":"J Ocul Pharmacol Ther","first-page":"38","article-title":"Pilot study of the safety and tolerability of a subconjunctival penciclovir implant in cats experimentally infected with herpesvirus","volume":"35","author":"Covert JC","year":"2019","unstructured":"Covert JC, Thomasy SM, Kado-Fong H, et al. Pilot study of the safety and tolerability of a subconjunctival penciclovir implant in cats experimentally infected with herpesvirus. J Ocul Pharmacol Ther. 2019;35(1):38\u201349. doi:10.1089\/jop.2018.0043"},{"key":"B10","series-title":"Res Vet Sci","first-page":"105909","article-title":"Ocular tolerance and tear film pharmacokinetics of 1% penciclovir cream in cats","volume":"196","author":"Pe\u2019er O","year":"2025","unstructured":"Pe\u2019er O, Thomasy SM, Feuer E, Knych HK, Ofri R, Sebbag L. Ocular tolerance and tear film pharmacokinetics of 1% penciclovir cream in cats. Res Vet Sci. 2025;196:105909. doi: 10.1016\/j.rvsc.2025.105909."},{"issue":"suppl","key":"B11","series-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod","first-page":"S12.e1","article-title":"Management of recurrent oral herpes simplex infections","volume":"103","author":"Woo SB","year":"2007","unstructured":"Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(suppl):S12.e1\u2013S12.e18. doi:10.1016\/j.tripleo.2006.11.004"},{"issue":"5","key":"B12","series-title":"Am J Vet Res","first-page":"490","article-title":"Effects of orally administered raltegravir in cats with experimentally induced ocular and respiratory feline herpesvirus-1 infection","volume":"80","author":"Spertus CB","year":"2019","unstructured":"Spertus CB, Pennington MR, Van de Walle GR, et al. Effects of orally administered raltegravir in cats with experimentally induced ocular and respiratory feline herpesvirus-1 infection. Am J Vet Res. 2019;80(5):490\u2013497. doi:10.2460\/ajvr.80.5.490"},{"issue":"2","key":"B13","series-title":"Cornell Vet","first-page":"232","article-title":"Feline viruses. VII. Immunity to the feline herpesvirus in kittens inoculated experimentally by the aerosol method","volume":"60","author":"Walton TE","year":"1970","unstructured":"Walton TE, Gillespie JH.Feline viruses. VII. Immunity to the feline herpesvirus in kittens inoculated experimentally by the aerosol method. Cornell Vet. 1970;60(2):232\u2013239."},{"issue":"6","key":"B14","series-title":"J Gen Virol","first-page":"1414","article-title":"A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1)","volume":"97","author":"Pennington MR","year":"2016","unstructured":"Pennington MR, Fort MW, Ledbetter EC, Van de Walle GR. A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1). J Gen Virol. 2016;97(6):1414\u20131425. doi:10.1099\/jgv.0.000451"},{"issue":"2","key":"B15","series-title":"mSphere","first-page":"e00039-17","article-title":"Electric cell-substrate impedance sensing to monitor viral growth and study cellular responses to infection with alphaherpesviruses in real time","volume":"2","author":"Pennington MR","year":"2017","unstructured":"Pennington MR, Van de Walle GR. Electric cell-substrate impedance sensing to monitor viral growth and study cellular responses to infection with alphaherpesviruses in real time. mSphere. 2017;2(2):e00039-17. doi:10.1128\/mSphere.00039-17"},{"key":"B16","series-title":"Virol J","first-page":"34","article-title":"Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture","volume":"11","author":"Semenkow SL","year":"2014","unstructured":"Semenkow SL, Johnson NM, Maggs DJ, Marguiles BJ. Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture. Virol J. 2014;11:34. doi:10.1186\/1743-422X-11-34"},{"issue":"1","key":"B17","series-title":"Pharmaceutics","first-page":"1","article-title":"Advancement on sustained antiviral ocular drug delivery for herpes simplex virus keratitis: recent update on potential investigation","volume":"13","author":"Pandey M","year":"2020","unstructured":"Pandey M, Choudhury H, Abdul-Aziz A, et al. Advancement on sustained antiviral ocular drug delivery for herpes simplex virus keratitis: recent update on potential investigation. Pharmaceutics. 2020;13(1):1. doi:10.3390\/pharmaceutics13010001"},{"issue":"2","key":"B18","series-title":"AAPS PharmSciTech","first-page":"66","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed S","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023;24(2):66. doi:10.1208\/s12249-023-02516-9"},{"issue":"6","key":"B19","series-title":"Arch Ophthalmol","first-page":"777","article-title":"Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis","volume":"116","author":"Kaufman HE","year":"1998","unstructured":"Kaufman HE, Varnell ED, Thompson HW. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Arch Ophthalmol. 1998;116(6):777\u2013780. doi:10.1001\/archopht.116.6.777"},{"issue":"17","key":"B20","series-title":"JAMA","first-page":"1374","article-title":"Penciclovir cream for the treatment of herpes simplex labialis","volume":"277","author":"Spruance SL","year":"1997","unstructured":"Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Bon R. Penciclovir cream for the treatment of herpes simplex labialis. JAMA. 1997;277(17):1374\u20131379. doi:10.1001\/jama.1997.03540410052030"},{"issue":"3","key":"B21","series-title":"Oral Dis","first-page":"254","article-title":"Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management","volume":"12","author":"Arduino PG","year":"2006","unstructured":"Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12(3):254\u2013270. doi:10.1111\/j.1601-0825.2006.01202.x"},{"issue":"1","key":"B22","series-title":"Clin Ther","first-page":"76","article-title":"Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir cream herpes labialis study group","volume":"22","author":"Boon R","year":"2000","unstructured":"Boon R, Goodman JJ, Martinez J, Marks ZBL, Gamble M, Welsch C. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir cream herpes labialis study group. Clin Ther. 2000;22(1):76\u201390. doi:10.1016\/s0149-2918(00)87979-5"},{"issue":"2","key":"B23","series-title":"J Dermatolog Treat","first-page":"67","article-title":"Topical application of penciclovir cream for the treatment of herpes simplex facialis\/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial","volume":"13","author":"Lin L","year":"2002","unstructured":"Lin L, Chen XS, Cui PG, et al. Topical application of penciclovir cream for the treatment of herpes simplex facialis\/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. J Dermatolog Treat. 2002;13(2):67\u201372. doi:10.1080\/095466302317584412"},{"issue":"7","key":"B24","series-title":"J Fam Pract","first-page":"576","article-title":"Clinical inquiries. What are the best treatments for herpes labialis?","volume":"56","author":"Chon R","year":"2007","unstructured":"Chon R, Nguyen L, Elliott TC. Clinical inquiries. What are the best treatments for herpes labialis? J Fam Pract. 2007;56(7):576\u2013578."},{"issue":"7","key":"B25","series-title":"Vet Rec","first-page":"128","article-title":"Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats","volume":"100","author":"Gaskell RM","year":"1977","unstructured":"Gaskell RM, Povey RC. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec. 1977;100(7):128\u2013133. doi:10.1136\/vr.100.7.128"},{"issue":"3","key":"B26","series-title":"J Am Dent Assoc","first-page":"303","article-title":"Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials","volume":"133","author":"Raborn GW","year":"2002","unstructured":"Raborn GW, Martel AY, Lassonde M, et al. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc. 2002;133(3):303\u2013309. doi:10.14219\/jada.archive.2002.0169"},{"issue":"4","key":"B27","series-title":"J Feline Med Surg","first-page":"353","article-title":"Effect of ciclosporin and methylprednisolone acetate on cats previously infected with feline herpesvirus 1","volume":"17","author":"Lappin MR","year":"2015","unstructured":"Lappin MR, Roycroft LM. Effect of ciclosporin and methylprednisolone acetate on cats previously infected with feline herpesvirus 1. J Feline Med Surg. 2015;17(4):353\u2013358. doi:10.1177\/1098612X14548865"},{"issue":"4","key":"B28","series-title":"Vet Ophthalmol","first-page":"382","article-title":"Detection of Mycoplasma spp. and feline calicivirus in cats with ocular surface disease","volume":"27","author":"Lewin AC","year":"2024","unstructured":"Lewin AC, Zhu X. Detection of Mycoplasma spp. and feline calicivirus in cats with ocular surface disease. Vet Ophthalmol. 2024;27(4):382\u2013387. doi:10.1111\/vop.13218"},{"issue":"2","key":"B1","series-title":"Vet Res","first-page":"337","article-title":"Feline herpesvirus","volume":"38","author":"Gaskell R","year":"2007","unstructured":"Gaskell R, Dawson S, Radford A, Thiry E. Feline herpesvirus. Vet Res. 2007;38(2):337\u2013354. doi:10.1051\/vetres:2006063"},{"issue":"5","key":"B2","series-title":"J Feline Med Surg","first-page":"333","article-title":"Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options","volume":"13","author":"Gould D","year":"2011","unstructured":"Gould D. Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options. J Feline Med Surg. 2011;13(5):333\u2013346. doi:10.1016\/j.jfms.2011.03.010"},{"issue":"2","key":"B3","series-title":"Am J Vet Res","first-page":"289","article-title":"Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats","volume":"69","author":"Fontenelle JP","year":"2008","unstructured":"Fontenelle JP, Powell CC, Veir JK, Radecki SV, Lappin MR. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. Am J Vet Res. 2008;69(2):289\u2013293. doi:10.2460\/ajvr.69.2.289"},{"issue":"5","key":"B4","series-title":"J Ocul Pharmacol Ther","article-title":"Comparative efficacy of topical ophthalmic ganciclovir and Oral famciclovir in cats with experimental ocular feline herpesvirus-1 epithelial infection","volume":"38","author":"Ledbetter EC","year":"2022","unstructured":"Ledbetter EC, Badanes ZI, Chan RX, et al. Comparative efficacy of topical ophthalmic ganciclovir and Oral famciclovir in cats with experimental ocular feline herpesvirus-1 epithelial infection. J Ocul Pharmacol Ther. 2022;38(5): doi:10.1089\/jop.2022.0001"},{"issue":"4","key":"B5","series-title":"Am J Vet Res","first-page":"399","article-title":"In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1","volume":"65","author":"Maggs DJ","year":"2004","unstructured":"Maggs DJ, Clarke HE. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res. 2004;65(4):399\u2013403. doi:10.2460\/ajvr.2004.65.399"},{"issue":"3","key":"B6","series-title":"Antiviral Res","first-page":"268","article-title":"Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase","volume":"78","author":"Hussein ITM","year":"2008","unstructured":"Hussein ITM, Menashy RB, Field HJ. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase. Antiviral Res. 2008;78(3):268\u2013274. doi:10.1016\/j.antiviral.2007.10.015"},{"issue":"1","key":"B7","series-title":"Am J Vet Res","first-page":"85","article-title":"Evaluation of orally administered famciclovir in cats experimentally infected with feline herpesvirus type-1","volume":"72","author":"Thomasy SM","year":"2011","unstructured":"Thomasy SM, Lim CC, Reilly CM, Kass PH, Lappin MR, Maggs DJ. Evaluation of orally administered famciclovir in cats experimentally infected with feline herpesvirus type-1. Am J Vet Res. 2011;72(1):85\u201395. doi:10.2460\/ajvr.72.1.85"},{"issue":"5","key":"B8","series-title":"J Am Vet Med Assoc","first-page":"526","article-title":"Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006\u20132013)","volume":"249","author":"Thomasy SM","year":"2016","unstructured":"Thomasy SM, Shull O, Outerbridge CA, et al. Oral administration of famciclovir for treatment of spontaneous ocular, respiratory, or dermatologic disease attributed to feline herpesvirus type 1: 59 cases (2006\u20132013). J Am Vet Med Assoc. 2016;249(5):526\u2013538. doi:10.2460\/javma.249.5.526"},{"issue":"1","key":"B9","series-title":"J Ocul Pharmacol Ther","first-page":"38","article-title":"Pilot study of the safety and tolerability of a subconjunctival penciclovir implant in cats experimentally infected with herpesvirus","volume":"35","author":"Covert JC","year":"2019","unstructured":"Covert JC, Thomasy SM, Kado-Fong H, et al. Pilot study of the safety and tolerability of a subconjunctival penciclovir implant in cats experimentally infected with herpesvirus. J Ocul Pharmacol Ther. 2019;35(1):38\u201349. doi:10.1089\/jop.2018.0043"},{"key":"B10","series-title":"Res Vet Sci","first-page":"105909","article-title":"Ocular tolerance and tear film pharmacokinetics of 1% penciclovir cream in cats","volume":"196","author":"Pe\u2019er O","year":"2025","unstructured":"Pe\u2019er O, Thomasy SM, Feuer E, Knych HK, Ofri R, Sebbag L. Ocular tolerance and tear film pharmacokinetics of 1% penciclovir cream in cats. Res Vet Sci. 2025;196:105909. doi: 10.1016\/j.rvsc.2025.105909."},{"issue":"suppl","key":"B11","series-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod","first-page":"S12.e1","article-title":"Management of recurrent oral herpes simplex infections","volume":"103","author":"Woo SB","year":"2007","unstructured":"Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(suppl):S12.e1\u2013S12.e18. doi:10.1016\/j.tripleo.2006.11.004"},{"issue":"5","key":"B12","series-title":"Am J Vet Res","first-page":"490","article-title":"Effects of orally administered raltegravir in cats with experimentally induced ocular and respiratory feline herpesvirus-1 infection","volume":"80","author":"Spertus CB","year":"2019","unstructured":"Spertus CB, Pennington MR, Van de Walle GR, et al. Effects of orally administered raltegravir in cats with experimentally induced ocular and respiratory feline herpesvirus-1 infection. Am J Vet Res. 2019;80(5):490\u2013497. doi:10.2460\/ajvr.80.5.490"},{"issue":"2","key":"B13","series-title":"Cornell Vet","first-page":"232","article-title":"Feline viruses. VII. Immunity to the feline herpesvirus in kittens inoculated experimentally by the aerosol method","volume":"60","author":"Walton TE","year":"1970","unstructured":"Walton TE, Gillespie JH.Feline viruses. VII. Immunity to the feline herpesvirus in kittens inoculated experimentally by the aerosol method. Cornell Vet. 1970;60(2):232\u2013239."},{"issue":"6","key":"B14","series-title":"J Gen Virol","first-page":"1414","article-title":"A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1)","volume":"97","author":"Pennington MR","year":"2016","unstructured":"Pennington MR, Fort MW, Ledbetter EC, Van de Walle GR. A novel corneal explant model system to evaluate antiviral drugs against feline herpesvirus type 1 (FHV-1). J Gen Virol. 2016;97(6):1414\u20131425. doi:10.1099\/jgv.0.000451"},{"issue":"2","key":"B15","series-title":"mSphere","first-page":"e00039-17","article-title":"Electric cell-substrate impedance sensing to monitor viral growth and study cellular responses to infection with alphaherpesviruses in real time","volume":"2","author":"Pennington MR","year":"2017","unstructured":"Pennington MR, Van de Walle GR. Electric cell-substrate impedance sensing to monitor viral growth and study cellular responses to infection with alphaherpesviruses in real time. mSphere. 2017;2(2):e00039-17. doi:10.1128\/mSphere.00039-17"},{"key":"B16","series-title":"Virol J","first-page":"34","article-title":"Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture","volume":"11","author":"Semenkow SL","year":"2014","unstructured":"Semenkow SL, Johnson NM, Maggs DJ, Marguiles BJ. Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture. Virol J. 2014;11:34. doi:10.1186\/1743-422X-11-34"},{"issue":"1","key":"B17","series-title":"Pharmaceutics","first-page":"1","article-title":"Advancement on sustained antiviral ocular drug delivery for herpes simplex virus keratitis: recent update on potential investigation","volume":"13","author":"Pandey M","year":"2020","unstructured":"Pandey M, Choudhury H, Abdul-Aziz A, et al. Advancement on sustained antiviral ocular drug delivery for herpes simplex virus keratitis: recent update on potential investigation. Pharmaceutics. 2020;13(1):1. doi:10.3390\/pharmaceutics13010001"},{"issue":"2","key":"B18","series-title":"AAPS PharmSciTech","first-page":"66","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed S","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023;24(2):66. doi:10.1208\/s12249-023-02516-9"},{"issue":"6","key":"B19","series-title":"Arch Ophthalmol","first-page":"777","article-title":"Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis","volume":"116","author":"Kaufman HE","year":"1998","unstructured":"Kaufman HE, Varnell ED, Thompson HW. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Arch Ophthalmol. 1998;116(6):777\u2013780. doi:10.1001\/archopht.116.6.777"},{"issue":"17","key":"B20","series-title":"JAMA","first-page":"1374","article-title":"Penciclovir cream for the treatment of herpes simplex labialis","volume":"277","author":"Spruance SL","year":"1997","unstructured":"Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Bon R. Penciclovir cream for the treatment of herpes simplex labialis. JAMA. 1997;277(17):1374\u20131379. doi:10.1001\/jama.1997.03540410052030"},{"issue":"3","key":"B21","series-title":"Oral Dis","first-page":"254","article-title":"Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management","volume":"12","author":"Arduino PG","year":"2006","unstructured":"Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12(3):254\u2013270. doi:10.1111\/j.1601-0825.2006.01202.x"},{"issue":"1","key":"B22","series-title":"Clin Ther","first-page":"76","article-title":"Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir cream herpes labialis study group","volume":"22","author":"Boon R","year":"2000","unstructured":"Boon R, Goodman JJ, Martinez J, Marks ZBL, Gamble M, Welsch C. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir cream herpes labialis study group. Clin Ther. 2000;22(1):76\u201390. doi:10.1016\/s0149-2918(00)87979-5"},{"issue":"2","key":"B23","series-title":"J Dermatolog Treat","first-page":"67","article-title":"Topical application of penciclovir cream for the treatment of herpes simplex facialis\/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial","volume":"13","author":"Lin L","year":"2002","unstructured":"Lin L, Chen XS, Cui PG, et al. Topical application of penciclovir cream for the treatment of herpes simplex facialis\/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. J Dermatolog Treat. 2002;13(2):67\u201372. doi:10.1080\/095466302317584412"},{"issue":"7","key":"B24","series-title":"J Fam Pract","first-page":"576","article-title":"Clinical inquiries. What are the best treatments for herpes labialis?","volume":"56","author":"Chon R","year":"2007","unstructured":"Chon R, Nguyen L, Elliott TC. Clinical inquiries. What are the best treatments for herpes labialis? J Fam Pract. 2007;56(7):576\u2013578."},{"issue":"7","key":"B25","series-title":"Vet Rec","first-page":"128","article-title":"Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats","volume":"100","author":"Gaskell RM","year":"1977","unstructured":"Gaskell RM, Povey RC. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec. 1977;100(7):128\u2013133. doi:10.1136\/vr.100.7.128"},{"issue":"3","key":"B26","series-title":"J Am Dent Assoc","first-page":"303","article-title":"Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials","volume":"133","author":"Raborn GW","year":"2002","unstructured":"Raborn GW, Martel AY, Lassonde M, et al. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc. 2002;133(3):303\u2013309. doi:10.14219\/jada.archive.2002.0169"},{"issue":"4","key":"B27","series-title":"J Feline Med Surg","first-page":"353","article-title":"Effect of ciclosporin and methylprednisolone acetate on cats previously infected with feline herpesvirus 1","volume":"17","author":"Lappin MR","year":"2015","unstructured":"Lappin MR, Roycroft LM. Effect of ciclosporin and methylprednisolone acetate on cats previously infected with feline herpesvirus 1. J Feline Med Surg. 2015;17(4):353\u2013358. doi:10.1177\/1098612X14548865"},{"issue":"4","key":"B28","series-title":"Vet Ophthalmol","first-page":"382","article-title":"Detection of Mycoplasma spp. and feline calicivirus in cats with ocular surface disease","volume":"27","author":"Lewin AC","year":"2024","unstructured":"Lewin AC, Zhu X. Detection of Mycoplasma spp. and feline calicivirus in cats with ocular surface disease. Vet Ophthalmol. 2024;27(4):382\u2013387. doi:10.1111\/vop.13218"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/87\/3\/ajvr.25.08.0304.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/87\/3\/ajvr.25.08.0304.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/87\/3\/ajvr.25.08.0304.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:40:41Z","timestamp":1772458841000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/87\/3\/ajvr.25.08.0304.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":56,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.25.08.0304","relation":{},"ISSN":["0002-9645","1943-5681"],"issn-type":[{"value":"0002-9645","type":"print"},{"value":"1943-5681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}